Nanoparticles mediated chiral interactions of pharmaceutical compounds: a combined SERS and DFT study
Rares Stiufiuc
University of Medicine and Pharmacy, Cluj-Napoca
He is Associate Professor in the Pharmaceutical Physics &Biophysics Department and Head of the BioNanoScopy Department at University of Medicine and Pharmacy, Cluj-Napoca, Romania.
He defended his Ph.D. Thesis in the field of Solid State Physics at Babes-Bolyai University Cluj-Napoca and Universite Paris Sud, Orsay France and spent 18 months as postodoctoral research associate at Institute dÉlectronique, Microelectronique et Nanotehnologie, Lille, France. His recent research activities are focused on the synthesis of different classes of multifunctional nanohybrids with applications in targeted drug delivery but also on developing new ultrasensitive techniques for biomolecules detection in biological fluids.
Abstract
The investigation of pharmaceutical compounds by means of Raman spectroscopy has attracted much interest in the last years. The method allows getting information about structural properties of different molecules based on... [ view full abstract ]
The investigation of pharmaceutical compounds by means of Raman spectroscopy has attracted much interest in the last years. The method allows getting information about structural properties of different molecules based on their specific vibrational structure. Nowadays Raman spectroscopy is gaining popularity in different areas of the pharmaceutical industry mainly due to its ability to provide information on the fundamental vibrational bands (the fingerprint region), offering a high degree of specificity in analysis1. It also forms an ideal complement for existing methods of analysis such as nuclear magnetic resonance, mass spectrometry and elemental analysis.
On the other hand chiral recognition and differentiation in living organisms represents one of the most intriguing natural phenomena, which assures in the organism a high fidelity transfer of the molecular information. This phenomenon has a significant role in the pharmaceutical industry, since chirality plays a key role in the development of target drug candidates, being a structural variable parameter that needs elucidation. In this context, the subject of chiral purity gained a particular importance in the pharmaceutical industry.
In this paper we will show that by taking advantage of the unique plasmonic properties of noble metal nanoparticles, the chiral separation of propranolol enantiomers was successfully studied and proved by Surface-Enhanced Raman Spectroscopy (SERS)2. The quantum chemistry calculations of native cyclodextrin - propranolol enantiomers complexes have been used as a further proof of the proposed interaction mechanism. It has been observed (experimentally and theoretically) that β-cyclodextrin (compared with the other two classes of native α and γ cyclodextrins) had the best chiral recognition ability for propranolol enantiomers, hence producing the largest difference in the SERS spectra of propranolol enantiomers - native cyclodextrin complexes.
Authors
-
Rares Stiufiuc
(University of Medicine and Pharmacy, Cluj-Napoca)
-
Cristian Iacovita
(Univ. Medicine and Pharmacy, Cluj-Napoca)
-
Gabriela Stiufiuc
("Babes-Bolyai" University Cluj-Napoca)
-
Vasile Chis
("Babes-Bolyai" University Cluj-Napoca)
-
Constantin Lucaciu
(Univ. Medicine and Pharmacy, Cluj-Napoca)
Topic Areas
Photonic & plasmonic nanomaterials , Optical properties of nanostructures
Session
OS1-101b » Photonic & plasmonic nanomaterials (16:30 - Wednesday, 7th December, Tower 24 - Room 101)
Presentation Files
The presenter has not uploaded any presentation files.